Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study

医学 回顾性队列研究 阶段(地层学) 比例危险模型 内科学 基底细胞 头颈部 肿瘤科 外科 古生物学 生物
作者
Yuan Zhi,Shaoming Li,Yizhan Li,Wenhao Ren,Ling Gao,Keqian Zhi
出处
期刊:Oral Oncology [Elsevier]
卷期号:154: 106849-106849 被引量:1
标识
DOI:10.1016/j.oraloncology.2024.106849
摘要

Oral squamous cell carcinoma (OSCC) is one of the most prevalent malignant tumors in head and neck. However, few studies have focused on the postoperative prognosis of elderly OSCC patients undergoing surgical resection and reconstruction. We conducted a retrospective study of 349 patients diagnosed OSCC in the Department of Oral and Maxillofacial Surgery, The Affiliated Hospital of Qingdao University from January 2016 to December 2022. Demographic and clinicopathological characteristics were recorded. Kaplan-Meier analysis was performed to identify the impact of age and reconstruction types on the prognosis of OSCC patients. Univariable regression analysis and multivariable Cox analysis were conducted to find independent prognostic factors of the younger and elderly OSCC patients. Among 349 OSCC patients included in this retrospective study, 241 (69.1 %) were elderly patients and 108 (30.9 %) were younger patients. The two groups were comparable according to the demographic records. The elderly group presented a better recurrence-specific prognosis than that of the younger group (RFS: p = 0.0324). There are no remarkable differences on the prognosis of different reconstructive types. Gender, current address, life habit, invasion patterns, and TNM stage were identified as independent prognostic factors of the younger and elderly OSCC patients. Elderly OSCC patients achieve a better recurrence-free survival than that of the younger patients. Meanwhile, the recurrence of OSCC patients is independent of their demographic and clinicopathological features. Elderly OSCC patients will benefit from aggressive surgical treatment as the younger patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
喜悦完成签到,获得积分10
刚刚
量子星尘发布了新的文献求助10
2秒前
4秒前
无限的千凝完成签到 ,获得积分10
4秒前
丘比特应助小侯采纳,获得10
4秒前
完美世界应助oldblack采纳,获得10
4秒前
5秒前
霍笑寒完成签到,获得积分10
5秒前
积极的雅寒完成签到 ,获得积分10
5秒前
5秒前
6秒前
俊逸的草莓完成签到,获得积分10
6秒前
7秒前
8秒前
英姑应助www采纳,获得10
8秒前
WFZ发布了新的文献求助10
9秒前
田様应助娜娜采纳,获得10
9秒前
ZXY完成签到,获得积分10
9秒前
9秒前
LINGXINYUE完成签到,获得积分10
10秒前
酷波er应助壮观手套采纳,获得10
11秒前
折耳根拌香菜完成签到,获得积分10
12秒前
13秒前
l900完成签到,获得积分10
13秒前
凡F完成签到 ,获得积分10
14秒前
奶茶一天一杯完成签到,获得积分10
14秒前
侯赛雷完成签到,获得积分10
14秒前
15秒前
15秒前
多情山蝶发布了新的文献求助10
16秒前
YC完成签到 ,获得积分10
17秒前
fa完成签到,获得积分10
17秒前
风吹似夏完成签到,获得积分10
17秒前
疯狂加载ing应助宁平凡采纳,获得50
17秒前
叶子发布了新的文献求助10
18秒前
Hello应助食量大如牛采纳,获得10
18秒前
啦啦啦啦啦完成签到 ,获得积分10
18秒前
你嵙这个期刊没买应助l900采纳,获得20
19秒前
19秒前
Joy发布了新的文献求助10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Terrorism and Power in Russia: The Empire of (In)security and the Remaking of Politics 1000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6044839
求助须知:如何正确求助?哪些是违规求助? 7813516
关于积分的说明 16246324
捐赠科研通 5190514
什么是DOI,文献DOI怎么找? 2777408
邀请新用户注册赠送积分活动 1760631
关于科研通互助平台的介绍 1643782